澳大利亚联邦新威尔士地区法院案号:[2013]FCA65判决时间:2013年2月15日阅读提示专利的适格性问题是本案关注的焦点。在本案中,涉案的专利权利要求包含了分离的DNA和RNA,对于包含有自然产生但已被分离的脱氧核糖核酸(DNA)和核糖核酸(RNA)的组合物是否属于澳大利亚1990年专利法第18条第1款第a项的“制造方法”是法院需要回答的问题。涉案DNA和RNA已从人体内的细胞中被提取出,并将其与其他细胞内的物质相分离。上述分离能否被认为产生了可辨别的人工状态, District Court of the District of New Wales, Australia Case No. [2013] FCA65 ​​Judgment: February 15, 2013 Read the Note The issue of the eligibility of a patent is the focus of the case. In the present case, the patent claims involved included isolated DNA and RNA as to whether or not a composition containing naturally occurring but isolated DNA and RNA belongs to the Australian Patent Act 1990 The “method of manufacture” of Article 18, paragraph 1 (a), is the question that the court needs to answer. The DNA and RNA involved have been extracted from cells in the human body and separated from other intracellular substances. Whether the above separation can be considered as producing a discernable artificial state,